Poll: In Light of the New Information Will You Start Recommending HRT for your Menopausal Patients?

Article

In a re-analysis of the WHI study 2002, the risks of HRT where misrepresented by the media and not corrected by those affiliated with the research.

In a re-analysis of the WHI study 2002, the risks of HRT where misrepresented by the media and not corrected by those affiliated with the research. According to the International Menopause Society, women needlessly suffer through severe menopause symptoms because of this. While there is a risk with HRT, it is modest with a slight increased risk of stroke, venous thromboembolism, and breast cancer. The benefits to women include an improved quality of life, reduced risk of heart disease, colorectal cancer, dementia and bone fracture. In light of the new information will you start recommending HRT for your menopausal patients?

Related Videos
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
Navigating vasomotor symptoms in breast cancer patients | Image Credit: menopausefoundationcanada.ca.
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit: uvahealth.com.
Hot flashes poorly impact sleep quality | Image Credit: intimmedicine.com
How to manage bone health in midlife women | Image Credit: - endocrine.org
Mary Jane Minkin, MD, discusses The Menopause Society 2023 Annual Meeting | Image Credit: Yale School of Medicine
Highlights from The Menopause Society 2023 Annual Meeting  | Image Credit: nursebarb.com
How fezolinetant changes management of hot flashes | Image Credit: medschool.cuanschutz.edu.
Related Content
© 2024 MJH Life Sciences

All rights reserved.